Claybrook Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-25,220
| Closed | -$1.84M | – | 132 |
|
|
2022
Q1 | $1.84M | Sell |
25,220
-1,100
| -4% | -$80.3K | 0.91% | 36 |
|
|
2021
Q4 | $1.64M | Buy |
+26,320
| New | +$1.64M | 0.77% | 39 |
|
|
2021
Q3 | – | Sell |
-39,731
| Closed | -$2.66M | – | 141 |
|
|
2021
Q2 | $2.66M | Buy |
+39,731
| New | +$2.66M | 0.87% | 35 |
|
|
2020
Q2 | – | Sell |
-25,639
| Closed | -$1.43M | – | 90 |
|
|
2020
Q1 | $1.43M | Sell |
25,639
-1,151
| -4% | -$64.2K | 1.3% | 28 |
|
|
2019
Q4 | $1.76M | Hold |
26,790
| – | – | 0.82% | 46 |
|
|
2019
Q3 | $1.36M | Buy |
26,790
+1,000
| +4% | +$50.7K | 0.7% | 51 |
|
|
2019
Q2 | $1.17M | Buy |
25,790
+2,200
| +9% | +$99.8K | 0.61% | 54 |
|
|
2019
Q1 | $1.13M | Buy |
23,590
+23,006
| +3,939% | +$1.1M | 0.59% | 55 |
|
|
2018
Q4 | $30K | Sell |
584
-6
| -1% | -$308 | 0.01% | 303 |
|
|
2018
Q3 | $37K | Hold |
590
| – | – | 0.02% | 119 |
|
|
2018
Q2 | $33K | Hold |
590
| – | – | 0.02% | 121 |
|
|
2018
Q1 | $37K | Sell |
590
-4,681
| -89% | -$294K | 0.02% | 115 |
|
|
2017
Q4 | $323K | Buy |
+5,271
| New | +$323K | 0.23% | 65 |
|